BeOne Medicines Ltd ADR
BeOne Medicines Ltd ADR (ONC) Unusual Options Activity Today
ONC options volume power reached 1x on the previous trading day. The highest reading was on the $350 CALL expiring 2026-10-16.
Read more
Checking ONC unusual options activity helps you spot when traders are making outsized bets on BeOne Medicines Ltd ADR before the broader market catches on. BeOne Medicines Ltd ADR's unusual options activity flags contracts trading at multiples of their average daily volume, often signaling that informed money is positioning ahead of a catalyst. Use our scanner to monitor ONC unusual options activity today and surface the prints that deserve a second look.
Unusual options flow typically refers to trades where volume vastly exceeds open interest at a given strike, or where total contract volume on a name spikes well above its norm. Watching ONC unusual options flow today can reveal large block trades, sweeps across exchanges, and aggressive directional bets. Tracking ONC unusual options volume across calls and puts helps you separate hedging activity from genuinely speculative positioning, and ONC unusual options flow data becomes especially valuable around earnings, product launches, and macro events.
BeOne Medicines, formerly known as BeiGene, is a global oncology company focused on discovering, developing, and commercializing innovative cancer therapies. Founded in 2010 and headquartered in Cambridge, Massachusetts—with operations spanning over 45 countries across six continents—the company rebranded as BeOne in late 2024 and redomiciled to Basel, Switzerland in 2025. BeOne has established itself as a leader in immuno-oncology and targeted therapies, with key assets including Tevimbra (tislelizumab), a PD-1 monoclonal antibody approved for multiple cancer indications globally, and Brukinsa (zanubrutinib), a Bruton's tyrosine kinase (BTK) inhibitor that surpassed $1.3 billion in annual sales and is approved in major markets such as the U.S., Europe, and China.
The company’s strategy combines internal R&D with the development of assets sourced from external partnerships, driving a robust pipeline across hematologic malignancies and solid tumors.
Catalysts rarely arrive without a footprint, and ONC unusual options activity is often where that footprint shows up first. Our scanner tracks BeOne Medicines Ltd ADR's unusual options flow in real time, ranks prints by volume-to-open-interest, premium spent, and aggressor side, and separates real conviction from noise. Whether you're looking at ONC unusual options volume on the call side or chasing put sweeps, BeOne Medicines Ltd ADR's unusual options flow today is one click away, so put it on your radar before the headlines hit.
| 430.00 | 0.50 | 2.25 | 1.38 | 53% | 6 | 12 | 50.00% |
| 400.00 | 0.05 | 4.80 | 2.43 | 40% | 1 | 30 | 3.33% |
| 230.00 | 134.30 | 138.60 | 136.45 | 90% | 0 | 0 | — |
| 240.00 | 124.10 | 128.60 | 126.35 | 26% | 0 | 0 | — |
| 250.00 | 114.10 | 118.70 | 116.40 | 64% | 0 | 0 | — |
| 230.00 | — | 3.60 | 3.60 | 162% | 0 | 0 | — |
| 240.00 | — | 3.40 | 3.40 | 147% | 0 | 0 | — |
| 250.00 | — | 3.40 | 3.40 | 136% | 0 | 0 | — |
| 260.00 | — | 3.40 | 3.40 | 125% | 0 | 0 | — |
| 270.00 | — | 3.40 | 3.40 | 114% | 0 | 0 | — |
As of September 30, 2026
Spot unusual options activity before it moves
Track ONC options flow across every expiration, filter by volume power, and find the setups with abnormal activity before the trade is gone.
Start your 14-day free trial→